⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
冠科生物与 Turbine 达成战略合作伙伴关系，以 AI + 类器官技术赋能转化肿瘤学创新
businesswire.com
AZN
MRK
FDA Approves Merck’s Once-Daily IDVYNSO™ (doravirine/islatravir)
businesswire.com
MRK
GILD
MilliporeSigma Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography
accessnewswire.com
MRK
BioInvent to Present Data of BI-1808 Plus KEYTRUDA(R) (Pembrolizumab) in Recurrent Ovarian Cancer at the 2026 ASCO Annual Meeting
accessnewswire.com
MRK
Global Nasal Sprays Market to Reach USD 29.7 Billion by 2036, Driven by Rising Allergy Cases and Non-Oral Drug Demand
prnewswire.com
GSK
JNJ
NVS
AZN
PFE
MRK
SNY
Merck Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography
globenewswire.com
MRK
MilliporeSigma Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography
globenewswire.com
MRK
Ray Therapeutics Announces Upsized and Oversubscribed $125 Million Series B Financing for Vision Restoration Treatments
businesswire.com
JHG
BEN
MRK
Immuno-Oncology Drugs Market Opportunity Analysis and Forecast Report 2026-2035: Merck & Co. Remains a Dominant Force, Supported by the Commercial Success of Keytruda
globenewswire.com
MRK
BMY
GILD
TAK
Oncolytic Virus Immunotherapy Market Landscape Report 2026: A $5 Opportunity by 2031 - Technology Platforms, Approved Therapy Dosage, Price & Clinical Trials Insights
globenewswire.com
MRK
BMY
AMGN
REPL